PMVP241220C5000
- 0.00
- 0.000.00%
PMV Pharmaceuticals Newsroom
Express News | PMV Pharmaceuticals Inc Files for Mixed Shelf of up to $200 Mln – SEC Filing
Oppenheimer Upgrades PMV Pharmaceuticals(PMVP.US) to Buy Rating, Announces Target Price $6
PMV Pharmaceuticals Upgraded to Outperform From Perform at Oppenheimer
TD Cowen Maintains PMV Pharmaceuticals(PMVP.US) With Buy Rating
Optimistic Buy Rating for PMV Pharmaceuticals Driven by Strategic Clinical Trials and Strong Financial Position
Express News | PMV Pharmaceuticals: Cash, Cash Equivalents, & Marketable Securities of $197.9 Mln as Sept 30, Providing Expected Cash Runway to End of 2026
PMV Pharmaceuticals | 10-Q: Q3 2024 Earnings Report
PMV Pharmaceuticals | 8-K: PMV Pharmaceuticals Reports Third Quarter 2024 Financial Results
Press Release: PMV Pharmaceuticals Reports Third Quarter 2024 Financial Results
PMV Pharmaceuticals 3Q Loss/Shr 37c >PMVP
Craig-Hallum Maintains PMV Pharmaceuticals(PMVP.US) With Buy Rating
Oppenheimer Maintains PMV Pharmaceuticals(PMVP.US) With Hold Rating
Oppenheimer Sticks to Its Hold Rating for PMV Pharmaceuticals (PMVP)
Express News | PMV Pharmaceuticals Inc - to Provide Interim Data by Mid-2025, Nda Submission by End of 2026
Express News | PMV Pharmaceuticals Inc - Collaborates With Mdacc and Msk for Phase 1B Study in Aml/Mds
PMV Pharmaceuticals Provides a Progress Update on PYNNACLE Clinical Trial
Express News | PMV Pharmaceuticals Provides a Progress Update on Pynnacle Clinical Trial
Penny Stocks To Buy With Just $1500: PMVP, BOLD, SPRO
PMV Pharmaceuticals (NASDAQ:PMVP) Is In A Good Position To Deliver On Growth Plans
H.C. Wainwright Maintains PMV Pharmaceuticals(PMVP.US) With Buy Rating, Maintains Target Price $5